A Prospective study of gas-assisted vitreomacular adhesion (VMA) release combined with intravitreal Ranibizumab in patients with exudative age-related macular degeneration
Latest Information Update: 17 Apr 2017
At a glance
- Drugs Perflutren (Primary) ; Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 17 Apr 2017 New trial record